Stay updated with breaking news from Cell Expansion. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
$15 million CIRM Grant Supports the Ongoing Phase 1 TRAVERSE Trial Evaluating ALLO-316 in Patients with Advanced or Metastatic Renal Cell Carcinoma ALLO-316 Illustrates Proof-of-Concept in RCC and...
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The
Pune, Jan. 04, 2024 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Transfusion Technology Market is...
[216 + Pages Research Study] According to a market research study published by Zion Market Research, the demand analysis of Global Trading Card Game Market...
Long Term Follow Up Data from Phase 1 ALPHA/ALPHA2 Trials Demonstrate Potential of Allogeneic CD19 CAR T to Generate Durable Complete Responses Similar to Approved Autologous Therapies Presentation Focused